Novotech   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Sydney New South Wales Australia (1996)

Organization Overview

First Clinical Trial
2010
NCT01189929
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

De Motu Cordis | Novotech (Australia) | Novotech (Australia) Pty Limited | THERAPIM PTY LTD